Low expression of HAUS4 and HAUS6 and high expression of HAUS1, HAUS3, HAUS5, HAUS7, HAUS8 may be risk factors for poor prognosis in glioma patients. This evidence concerns the gene HAUS8 and central nervous system cancer.